ECL - Ecolab Inc.
NYSE
->
Basic Materials
->
Specialty Chemicals
Saint Paul,
United States
Type: Equity
ECL price evolution
ECL
| (in millions $) | 31 Dec 2023 | 30 Oct 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $919.5 | $1001.3 | $554.2 | $419.4 |
| Short term investments | ||||
| Net receivables | $2834.2 | $2823.5 | $2780.1 | $2667.8 |
| Inventory | $1497.2 | $1536 | $1646.2 | $1727.3 |
| Total current assets | $5644.1 | $5789.4 | $5436.5 | $5272.8 |
| Long term investments | ||||
| Property, plant & equipment | $4028.1 | $3868.8 | $3773.3 | $3743.3 |
| Goodwill & intangible assets | $11641.7 | $11627 | $11704.9 | $11679 |
| Total noncurrent assets | $16202.5 | $16068.7 | $16019.7 | $15978.7 |
| Total investments | ||||
| Total assets | $21846.6 | $21858.1 | $21456.2 | $21251.5 |
| Current liabilities | ||||
| Accounts payable | $1566.3 | $1498.8 | $1476.8 | $1469.9 |
| Deferred revenue | ||||
| Short long term debt | $630.4 | $1129.1 | $1121.9 | $1118.1 |
| Total current liabilities | $4345.8 | $4600.5 | $4467.5 | $4489.6 |
| Long term debt | $7976.9 | $7902.1 | $7835 | $7845.1 |
| Total noncurrent liabilities | $9428.6 | $9435.1 | $9408.2 | $9396.9 |
| Total debt | $8607.3 | $9031.2 | $8956.9 | $8963.2 |
| Total liabilities | $13774.4 | $14035.6 | $13875.7 | $13886.5 |
| Shareholders' equity | ||||
| Retained earnings | $10075.4 | $9832.8 | $9580 | $9401.3 |
| Other shareholder equity | -$1850.4 | -$1801.4 | -$1761.8 | -$1737.2 |
| Total shareholder equity | $8044.7 | $7795.8 | $7556.7 | $7344.2 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $919.5 | $598.6 | $359.9 | $1260.2 |
| Short term investments | ||||
| Net receivables | $2834.2 | $2698.1 | $2478.4 | $2273.8 |
| Inventory | $1497.2 | $1792.8 | $1491.8 | $1285.2 |
| Total current assets | $5644.1 | $5494.2 | $4687.1 | $5117.4 |
| Long term investments | ||||
| Property, plant & equipment | $4028.1 | $3741.6 | $3685.3 | $3548.7 |
| Goodwill & intangible assets | $11641.7 | $11693.4 | $12288 | $8983.9 |
| Total noncurrent assets | $16202.5 | $15970.1 | $16519.3 | $13008.6 |
| Total investments | ||||
| Total assets | $21846.6 | $21464.3 | $21206.4 | $18126 |
| Current liabilities | ||||
| Accounts payable | $1566.3 | $1728.2 | $1384.2 | $1160.6 |
| Deferred revenue | ||||
| Short long term debt | $630.4 | $505.1 | $411 | $17.3 |
| Total current liabilities | $4345.8 | $4210.4 | $3553.2 | $2932.2 |
| Long term debt | $7976.9 | $8075.3 | $8629.8 | $6969.8 |
| Total noncurrent liabilities | $9428.6 | $9995.3 | $10400.1 | $8992.3 |
| Total debt | $8607.3 | $8918.2 | $9040.8 | $6987.1 |
| Total liabilities | $13774.4 | $14228.2 | $13953.3 | $11924.5 |
| Shareholders' equity | ||||
| Retained earnings | $10075.4 | $9318.8 | $8814.5 | $8243 |
| Other shareholder equity | -$1850.4 | -$1726.6 | -$1634.8 | -$1994.4 |
| Total shareholder equity | $8044.7 | $7236.1 | $7224.2 | $6166.5 |
| (in millions $) | 31 Dec 2023 | 30 Oct 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3938.4 | $3852.1 | $3571.6 | |
| Cost of revenue | $2284.4 | $2334.8 | $2205.2 | |
| Gross Profit | $1654 | $1517.3 | $1366.4 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1034.8 | $1011.6 | $990.3 | |
| Total operating expenses | $1064 | $1032.6 | $1014.8 | |
| Operating income | $590 | $484.7 | $351.6 | |
| Income from continuing operations | ||||
| EBIT | $602.3 | $494.1 | $360 | |
| Income tax expense | $126.7 | $86.6 | $52.4 | |
| Interest expense | $70.4 | $77.8 | $74.2 | |
| Net income | ||||
| Net income | $405.2 | $329.7 | $233.4 | |
| Income (for common shares) | $405.2 | $329.7 | $233.4 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $15320.2 | $14187.8 | $12733.1 | $11790.2 |
| Cost of revenue | $9154.9 | $8831 | $7615.8 | $6905.8 |
| Gross Profit | $6165.3 | $5356.8 | $5117.3 | $4884.4 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $4061.6 | $3653.8 | $3416.1 | $3309.1 |
| Total operating expenses | $4173 | $3794.3 | $3518.7 | $3488.7 |
| Operating income | $1992.3 | $1562.5 | $1598.6 | $1395.7 |
| Income from continuing operations | ||||
| EBIT | $2031.5 | $1569.8 | $1618.4 | -$738.3 |
| Income tax expense | $362.5 | $234.5 | $270.2 | $176.6 |
| Interest expense | $296.7 | $243.6 | $218.3 | $290.2 |
| Net income | ||||
| Net income | $1372.3 | $1091.7 | $1129.9 | -$1205.1 |
| Income (for common shares) | $1372.3 | $1091.7 | $1129.9 | -$1205.1 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $405.2 | $404 | $329.7 | $233.4 |
| Operating activities | ||||
| Depreciation | $230.5 | $229.4 | $229.4 | $234.3 |
| Business acquisitions & disposals | -$73.6 | -$1.8 | -$105 | |
| Stock-based compensation | $21.7 | $14.7 | $27.3 | $31.4 |
| Total cash flows from operations | $852.5 | $787.7 | $573.4 | $198.2 |
| Investing activities | ||||
| Capital expenditures | -$262.2 | -$165.6 | -$168.2 | -$168.9 |
| Investments | ||||
| Total cash flows from investing | -$348.4 | -$178.6 | -$274.1 | -$189.4 |
| Financing activities | ||||
| Dividends paid | -$154.7 | -$154 | -$150.9 | -$157.7 |
| Sale and purchase of stock | -$2 | -$0.8 | -$0.3 | -$10.6 |
| Net borrowings | -$501.6 | -$2 | -$3.8 | $5.5 |
| Total cash flows from financing | -$585.5 | -$147 | -$155.8 | -$166.4 |
| Effect of exchange rate | -$0.4 | -$15 | -$8.7 | -$21.6 |
| Change in cash and equivalents | -$81.8 | $447.1 | $134.8 | -$179.2 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $1372.3 | $1091.7 | $1129.9 | -$1205.1 |
| Operating activities | ||||
| Depreciation | $923.6 | $938.7 | $843.1 | $812.7 |
| Business acquisitions & disposals | -$180.4 | -$7.2 | -$3923.7 | -$370.8 |
| Stock-based compensation | $95.1 | $87.8 | $89.5 | $82.1 |
| Total cash flows from operations | $2411.8 | $1788.4 | $2061.9 | $1860.2 |
| Investing activities | ||||
| Capital expenditures | -$764.9 | -$710.6 | -$630.8 | -$483.7 |
| Investments | ||||
| Total cash flows from investing | -$990.5 | -$716.8 | -$4579.7 | -$414.5 |
| Financing activities | ||||
| Dividends paid | -$617.3 | -$602.8 | -$566.4 | -$560.8 |
| Sale and purchase of stock | -$13.7 | -$518.2 | -$106.6 | -$146.2 |
| Net borrowings | -$501.9 | $89.7 | $2121.3 | $143.3 |
| Total cash flows from financing | -$1054.7 | -$837.3 | $1603.2 | -$341.8 |
| Effect of exchange rate | -$45.7 | $4.4 | $14.3 | -$30.1 |
| Change in cash and equivalents | $320.9 | $238.7 | -$900.3 | $1073.8 |
News
|
Will Materials ETFs Gain Further as Q1 Earnings Unfold?
Zacks via Yahoo Finance
18 Apr 2024
|
|
Why You Should Add Inspire Medical (INSP) to Your Portfolio
Zacks via Yahoo Finance
18 Apr 2024
|
|
CF Industries (CF), JERA Execute Joint Development Agreement
Zacks via Yahoo Finance
18 Apr 2024
|
|
Piedmont Lithium's (PLL) Project Gets Mining Permit Approval
Zacks via Yahoo Finance
16 Apr 2024
|
|
ATI Announces Completion of Vandergrift Operations Expansion
Zacks via Yahoo Finance
15 Apr 2024
|
|
Eldorado Gold (EGO) Updates on Q1 Tax Impacts in Turkiye
Zacks via Yahoo Finance
12 Apr 2024
|
|
Ecolab stock upgraded to Buy on strong earnings momentum By Investing.com
Investing.com
12 Apr 2024
|
|
DOW Boosts Automotive Partnerships in Europe With New Studio
Zacks via Yahoo Finance
12 Apr 2024
|
|
Here's Why You Should Add DaVita (DVA) to Your Portfolio
Zacks via Yahoo Finance
11 Apr 2024
|
|
16 Best Materials Stocks To Buy in 2024
Insider Monkey via Yahoo Finance
10 Apr 2024
|
Fundamentals
| Market cap | $62.21B |
|---|---|
| Enterprise value | $69.89B |
| Shares outstanding | 285.14M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 7.28% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 6.29 |
| Book/Share | 34.70 |
| Cash/Share | 3.22 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.71 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.30 |
| Quick ratio | 0.95 |